Bionime Corp
TWSE:4737

Watchlist Manager
Bionime Corp Logo
Bionime Corp
TWSE:4737
Watchlist
Price: 55.9 TWD 2.01%
Market Cap: NT$4.3B

Bionime Corp
Investor Relations

Bionime Corp. engages in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company is headquartered in Taichung, Taichung. The company went IPO on 2009-08-26. The firm's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The firm distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.

Show more
Loading
4737
Taiwan Weighted Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Chun-Mu Huang
Founder, Chairman & GM
No Bio Available
Sherry Huang
Manager of Human Resources Department & Financial Officer
No Bio Available
Mr. Yu-Jen Hsiu
Assistant General Manager of Operation Division
No Bio Available
Ms. Hui-Zhen Chen
Assistant GM of Administration Division & Corporate Governance Officer
No Bio Available
Zhen Teng Xu
Vice President of Research and Development
No Bio Available
Mr. Cheng-Hong Shi
Assistant General Manager of Sales Division
No Bio Available
Mr. Ming-Lun Zhang
Assistant General Manager of Marketing Planning Division
No Bio Available

Contacts

Address
TAICHUNG
TAICHUNG
No.100, Section 2, Daqing Street, South District
Contacts
+886423692388
www.bionime.com